The Uromigos Episode 25: Dr. Tian Zhang on First-Line Treatment for Renal Cancer and the PDIGREE Trial

Dr. Tian Zhang, assistant professor of medicine at Duke Cancer Institute at the Duke School of Medicine, discusses the phase 3 PDIGREE Trial for first-line treatment of metastatic clear cell renal cell carcinoma, as well as first-line treatment for renal cancer in general.